Abstract:DddA-derived cytosine base editors (DdCBEs) enable the targeted introduction of C·G-to-T·A conversions in mitochondrial DNA (mtDNA). DdCBEs are often deployed as pairs, with each arm comprised of a transcription activator-like effector (TALE), a split double-stranded DNA deaminase half, and a uracil glycosylase inhibitor. This pioneering technology has helped improve our understanding of cellular processes involving mtDNA and has paved the way for the development of models and therapies for genetic disorders caused by pathogenic mtDNA variants. Nonetheless, given the intrinsic properties of TALE proteins, several target sites in human mtDNA remain out of reach to DdCBEs and other TALE-based technologies. Specifically, due to the conventional requirement for a thymine immediately upstream of the TALE target sequences (i.e., the 5′-T constraint), over 150 loci in the human mitochondrial genome are presumed to be inaccessible to DdCBEs. Previous attempts at circumventing this constraint, either by developing monomeric DdCBEs or utilizing DNA-binding domains alternative to TALEs, have resulted in suboptimal specificity profiles with reduced therapeutic potential. Here, aiming to challenge and elucidate the relevance of the 5′-T constraint in the context of DdCBE-mediated mtDNA editing, and to expand the range of motifs that are editable by this technology, we generated αDdCBEs that contain modified TALE proteins engineered to recognize all 5′ bases. Notably, 5′-T-noncompliant, canonical DdCBEs efficiently edited mtDNA at diverse loci. However, DdCBEs were frequently outperformed by αDdCBEs, which consistently displayed significant improvements in activity and specificity, regardless of the 5′-most bases of their TALE binding sites. Furthermore, we showed that αDdCBEs are compatible with DddAtox and its derivatives DddA6, and DddA11, and we validated TALE shifting with αDdCBEs as an effective approach to optimize base editing outcomes at a single target site. Overall, αDdCBEs enable efficient, specific, and unconstrained mitochondrial base editing.

Streamlined process for effective and strand-selective mitochondrial base editing using mitoBEs

Strand-selective base editing of human mitochondrial DNA using mitoBEs

Enhanced C‐To‐T and A‐To‐G Base Editing in Mitochondrial DNA with Engineered DdCBE and TALED

Engineered mitochondrial A-to-G editors with enhanced efficiency and targeting scope

Unconstrained Precision Mitochondrial Genome Editing with αDdCBEs

Harnessing accurate mitochondrial DNA base editing mediated by DdCBEs in a predictable manner

Developing Mitochondrial Base Editors with Diverse Context Compatibility and High Fidelity Via Saturated Spacer Library

Precision mitochondrial DNA editing with high-fidelity DddA-derived base editors

A Novel Double-Stranded DNA Deaminase-Based and Transcriptional Activator-Assisted Nuclear and Mitochondrial Cytosine Base Editors with Expanded Target Compatibility and Enhanced Activity

Eliminating Base-Editor-induced Genome-Wide and Transcriptome-Wide Off-Target Mutations

The FusX TALE Base Editor (FusXTBE) for Rapid Mitochondrial DNA Programming of Human Cells In Vitro and Zebrafish Disease Models In Vivo

Research Progress in Mitochondrial Gene Editing Technology.

Mitochondrial base editor induces substantial nuclear off-target mutations

CRISPR-free, strand-selective mitochondrial DNA base editing using a nickase

CRISPR/Cas9-mediated base editors and their prospects for mitochondrial genome engineering

Tools for editing the mammalian mitochondrial genome

A DddA ortholog-based and transactivator-assisted nuclear and mitochondrial cytosine base editors with expanded target compatibility

Design and application of the transformer base editor in mammalian cells and mice

DdCBE Mediates Efficient and Inheritable Modifications in Mouse Mitochondrial Genome.

Improving adenine and dual base editors through introduction of TadA-8e and Rad51DBD

Engineering RsDddA as mitochondrial base editor with wide target compatibility and enhanced activity